Marinomed Biotech AG buy Savour
Start price
06.03.21
/
0%
€143.00
Target price
06.03.22
-
Performance (%)
-37.76%
End price
21.12.21
€89.00
Summary
This prediction ended on 21.12.21 with a price of €89.00. Massive losses of -37.76% were the result for the BUY prediction by Savour. This prediction was marked as speculative and is excluded from Savour's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Marinomed Biotech AG | - | - | - | - |
| iShares Core DAX® | 0.611% | -2.723% | 14.325% | 14.359% |
| iShares Nasdaq 100 | -0.208% | 6.703% | 37.781% | 55.710% |
| iShares Nikkei 225® | 1.298% | 1.009% | 9.641% | 4.825% |
| iShares S&P 500 | 0.636% | 5.035% | 30.827% | 48.685% |
According to Savour what are the pros and cons of Marinomed Biotech AG for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Savour for this prediction
In the thread Marinomed Biotech AG diskutieren
Buy Marinomed Biotech AG